Feb. 17 at 3:24 PM
$APVO I don't believe it can go much lower. Major pipeline news is coming soon. This may be your last opportunity to get in at this level. I'm also predicting before the end of 2028, this company is acquired in full by major Pharma. It will never make a single dollar, but that acquisition will still be a
$1 Billion deal. They can survive as a clinical stage company until 2030...but won't need to hang on that long in my opinion. Some big Pharma co. is not going to wait until full FDA approval of Mipletamig. If they wait that long, they will have to pay double. The more likely scenario is favorable Phase III data in the first half of that trials level will lead to a move.
